Article thumbnail

Comprehensive exon array data processing method for quantitative analysis of alternative spliced variants

By Ping Chen, Tatiana Lepikhova, Yizhou Hu, Outi Monni and Sampsa Hautaniemi

Abstract

Alternative splicing of pre-mRNA generates protein diversity. Dysfunction of splicing machinery and expression of specific transcripts has been linked to cancer progression and drug response. Exon microarray technology enables genome-wide quantification of expression levels of the majority of exons and facilitates the discovery of alternative splicing events. Analysis of exon array data is more challenging than the analysis of gene expression data and there is a need for reliable quantification of exons and alternatively spliced variants. We introduce a novel, computationally efficient methodology, Multiple Exon Array Preprocessing (MEAP), for exon array data pre-processing, analysis and visualization. We compared MEAP with existing pre-processing methods, and validation of six exons and two alternatively spliced variants with qPCR corroborated MEAP expression estimates. Analysis of exon array data from head and neck squamous cell carcinoma (HNSCC) cell lines revealed several transcripts associated with 11q13 amplification, which is related with decreased survival and metastasis in HNSCC patients. Our results demonstrate that MEAP produces reliable expression values at exon, alternatively spliced variant and gene levels, which allows generating novel experimentally testable predictions

Topics: Methods Online
Publisher: Oxford University Press
OAI identifier: oai:pubmedcentral.nih.gov:3185423
Provided by: PubMed Central

Suggested articles

Citations

  1. (2002). A genomic view of alternative splicing.
  2. (2008). Aberrant RNA splicing and its functional consequences in cancer cells.
  3. (2002). Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.
  4. (2010). Aittoma ¨ ki,V.,
  5. (2009). Alternative splicing and disease.
  6. (2007). Alternative splicing in cancer: noise, functional, or systematic?
  7. (2003). Alternative splicing of the actin binding domain of human cortactin affects cell migration.
  8. (2005). Alternative transcript analysis methods for exon arrays. Affymetrix Whitepaper,
  9. (2001). Amplification and expression of splice variants of the gene encoding the P450 cytochrome 25-hydroxyvitamin D(3) 1,alpha-hydroxylase (CYP 27B1) in human malignant glioma.
  10. (1997). Amplification of 11q13 DNA markers in head and neck squamous cell carcinomas: correlation with clinical outcome.
  11. (2006). Amplifications of TAOS1 and EMS1 genes in oral carcinogenesis: association with clinicopathological features.
  12. (2010). ANO1 amplification and expression in HNSCC with a high propensity for future distant metastasis and its functions in HNSCC cell lines.
  13. (2002). Chromosomal alterations during metastasis formation of head and neck squamous cell carcinoma.
  14. (2008). Comprehensive analysis of Affymetrix exon arrays using BioConductor.
  15. (2008). Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing.
  16. (2004). Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper– Excel-based tool using pair-wise correlations.
  17. (2007). Discovery of tissue-specific exons using comprehensive human exon microarrays.
  18. (2009). Exon array analysis of head and neck cancers identifies a hypoxia related splice variant of LAMA3 associated with a poor prognosis.
  19. (2009). Exon Array Analyzer: a web interface for Affymetrix exon array analysis.
  20. (2005). Exon array background correction.
  21. (2007). Exon arrays provide accurate assessments of gene expression.
  22. (2011). Function of liprins in cell motility.
  23. (2003). Gene structure-based splice variant deconvolution using a microarray platform.
  24. (2008). High-resolution copy number and gene expression microarray analyses of head and neck squamous cell carcinoma cell lines of tongue and larynx.
  25. (1999). Highly sensitive and specific fluorescence reverse transcription-PCR assay for the pseudogene-free detection of beta-actin transcripts as quantitative reference.
  26. (1997). Identification and characterization of neogenin, a DCC-related gene.
  27. (2003). Identification and functional analysis of human transcriptional promoters.
  28. (2010). Improvements to previous algorithms to predict gene structure and isoform concentrations using Affymetrix Exon arrays.
  29. (2007). Inhibitor of growth 4 suppresses cell spreading and cell migration by interacting with a novel binding partner, liprin alpha1.
  30. (2010). Integrative analysis of DNA copy number and gene expression in metastatic oral squamous cell carcinoma identifies genes associated with poor survival.
  31. (2004). Linear models and empirical Bayes methods for assessing differential expression in microarray experiments.
  32. (2010). Liprin-alpha1 regulates breast cancer cell invasion by affecting cell motility, invadopodia and extracellular matrix degradation.
  33. (2008). MADS: a new and improved method for analysis of differential alternative splicing by exon-tiling microarrays.
  34. (2010). MADS+: discovery of differential splicing events from Affymetrix exon junction array data.
  35. (1996). Matrix Computations, 3rd edn. The Johns Hopkins
  36. (2006). Model-based analysis of tiling-arrays for ChIP-chip.
  37. (1997). Mouse Neogenin, a DCC-like molecule, has four splice variants and is expressed widely in the adult mouse and during embryogenesis.
  38. (2005). Neogenin expression may be inversely correlated to the tumorigenicity of human breast cancer.
  39. (1994). Neogenin, an avian cell surface protein expressed during terminal neuronal differentiation, is closely related to the human tumor suppressor molecule deleted in colorectal cancer.
  40. (2007). Neogenin: a multi-functional receptor regulating diverse developmental processes.
  41. (2007). Neogenin: one receptor, many functions.
  42. (2004). Open MPI: goals, concept, and design of a next generation MPI implementation.
  43. (2010). Oral cancer overexpressed 1 (ORAOV1) regulates cell cycle and apoptosis in cervical cancer HeLa cells.
  44. (2008). Oral cancer overexpressed 1 (ORAOV1): a regulator for the cell growth and tumor angiogenesis in oral squamous cell carcinoma.
  45. (2009). Probe-level estimation improves the detection of differential splicing in Affymetrix exon array studies.
  46. (2003). Profiling follicle stimulating hormone-induced gene expression changes in normal and malignant human ovarian surface epithelial cells.
  47. (2009). Regulation of TMEM16A chloride channel properties by alternative splicing.
  48. (2010). Rmpi: interface (Wrapper) to MPI (Message-Passing Interface).
  49. (2008). SPACE: an algorithm to predict and quantify alternatively spliced isoforms using microarrays.
  50. (2003). Summaries of Affymetrix GeneChip probe level data.
  51. (2006). TAOS1, a novel marker for advanced esophageal squamous cell carcinoma.
  52. (2008). The Cancer Genome Atlas Research Network
  53. (2009). The mouse and human Liprin-alpha family of scaffolding proteins: genomic organization, expression profiling and regulation by alternative splicing.
  54. (2008). TMEM16A, a membrane protein associated with calcium-dependent chloride channel activity.
  55. (2008). Tyrosine phosphorylation of netrin receptors in netrin-1 signaling.
  56. (2007). Widespread mRNA polyadenylation events in introns indicate dynamic interplay between polyadenylation and splicing.
  57. (2008). X:Map: annotation and visualization of genome structure for Affymetrix exon array analysis.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.